NASDAQ:TACT - TransAct Technologies Stock Price, News, & Analysis

TransAct Technologies trades on the NASDAQ under the ticker symbol "TACT."

TransAct Technologies declared a quarterly dividend on Wednesday, May 1st. Shareholders of record on Monday, May 20th will be paid a dividend of $0.09 per share on Friday, June 14th. This represents a $0.36 dividend on an annualized basis and a yield of 4.05%. The ex-dividend date is Friday, May 17th. View TransAct Technologies' Dividend History.

TransAct Technologies announced that its Board of Directors has initiated a share buyback program on Tuesday, March 6th 2018, which allows the company to repurchase $5,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board of directors believes its shares are undervalued.

TransAct Technologies Incorporated (NASDAQ:TACT) posted its quarterly earnings data on Tuesday, May, 7th. The technology company reported $0.10 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.05 by $0.05. The technology company had revenue of $11.55 million for the quarter. TransAct Technologies had a return on equity of 20.55% and a net margin of 10.19%. View TransAct Technologies' Earnings History.

TransAct Technologies is scheduled to release their next quarterly earnings announcement on Thursday, August 1st 2019. View Earnings Estimates for TransAct Technologies.

1 equities research analysts have issued 12-month target prices for TransAct Technologies' shares. Their predictions range from $14.00 to $14.00. On average, they anticipate TransAct Technologies' share price to reach $14.00 in the next twelve months. This suggests a possible upside of 57.7% from the stock's current price. View Analyst Price Targets for TransAct Technologies.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TransAct Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for TransAct Technologies.

Press coverage about TACT stock has trended somewhat positive recently, according to InfoTrie. The research firm scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. TransAct Technologies earned a daily sentiment score of 1.9 on InfoTrie's scale. They also gave media stories about the technology company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Some companies that are related to TransAct Technologies include Immersion (IMMR), AstroNova (ALOT), RADCOM (RDCM), Identiv (INVE), RadiSys (RSYS), Key Tronic (KTCC), Top Image Systems (TISA), Interlink Electronics (LINK), IGO (IGOI), Hauppauge Digital (HAUP) and HTC (HTCXF).

Based on aggregate information from My MarketBeat watchlists, some companies that other TransAct Technologies investors own include Allena Pharmaceuticals (ALNA), REDHILL BIOPHAR/S (RDHL), Veru (VERU), Viking Therapeutics (VKTX), Palatin Technologies (PTN), Cerecor (CERC), Sorrento Therapeutics (SRNE), Viewray (VRAY), SEASPAN CORP/SH SH (ssw) and Ampliphi Biosciences (APHB).

TransAct Technologies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (5.67%), Dimensional Fund Advisors LP (4.25%), Cowen Prime Services LLC (3.34%), North Star Investment Management Corp. (1.59%), Teton Advisors Inc. (1.56%) and Acadian Asset Management LLC (0.85%). Company insiders that own TransAct Technologies stock include Andrew John Hoffman, Bart C Shuldman, David B Peters, Graham Y Tanaka, Haydee Olinger, John Dillon, Steven A Demartino, Thomas R Schwarz and Tracey S Chernay. View Institutional Ownership Trends for TransAct Technologies.

TACT stock was sold by a variety of institutional investors in the last quarter, including Cowen Prime Services LLC, Acadian Asset Management LLC, Gabelli Funds LLC, O Shaughnessy Asset Management LLC, JPMorgan Chase & Co. and Teton Advisors Inc.. Company insiders that have sold TransAct Technologies company stock in the last year include Bart C Shuldman, David B Peters, Graham Y Tanaka, Steven A Demartino, Thomas R Schwarz and Tracey S Chernay. View Insider Buying and Selling for TransAct Technologies.

TACT stock was purchased by a variety of institutional investors in the last quarter, including Cowen Prime Services LLC, Dimensional Fund Advisors LP, Wedge Capital Management L L P NC, North Star Investment Management Corp., Renaissance Technologies LLC, LSV Asset Management, Connors Investor Services Inc. and Cable Hill Partners LLC. Company insiders that have bought TransAct Technologies stock in the last two years include Haydee Olinger and John Dillon. View Insider Buying and Selling for TransAct Technologies.

Shares of TACT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of TACT stock can currently be purchased for approximately $8.88.

TransAct Technologies has a market capitalization of $66.24 million and generates $54.59 million in revenue each year. The technology company earns $5.43 million in net income (profit) each year or $0.70 on an earnings per share basis. TransAct Technologies employs 126 workers across the globe.

The official website for TransAct Technologies is http://www.transact-tech.com.

TransAct Technologies' mailing address is ONE HAMDEN CENTER 2319 WHITNEY AVENUE SUITE 3B, HAMDEN CT, 06518. The technology company can be reached via phone at 203-859-6800 or via email at [email protected]